Insider · CIK 0001786754
Gunnar F. Kaufmann
Files at ONCT (Oncternal Therapeutics, Inc.). First filing Jun 14, 2023, latest Jun 14, 2023.
In brief
Gunnar F. Kaufmann files SEC Form 4 as officer at ONCT (Oncternal Therapeutics, Inc.). Since Jun 14, 2023, Gunnar F. Kaufmann has reported 1 open-market buy worth $9,824 and 0 open-market sells worth $0, the latest filed on Jun 14, 2023.
A track record needs three past buys with six months of prices behind them; Gunnar F. Kaufmann has 0, so none is measured yet.
The newest scored trade: bought $9,824 of ONCT on Jun 12, 2023, filed Jun 14, 2023, scored 21 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | ONCTbuy Oncternal Therapeutics, Inc. | $9,824 28,000 shares | +42% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2023 | ONCT Oncternal Therapeutics, Inc. | POpen-market purchase Common Stock | +25,000 | $0.35 | $8,745 | 91,726 | Jun 14, 2023 |
| Jun 14, 2023 | ONCT Oncternal Therapeutics, Inc. | POpen-market purchase Common Stock | +3,000 | $0.36 | $1,079 | 94,726 | Jun 14, 2023 |
| Feb 21, 2023 | ONCT Oncternal Therapeutics, Inc. | AGrant or award Stock Optionderivative | +210,000 | $0.00 | $0 | 210,000 | Feb 23, 2023 |
| Jan 3, 2023 | ONCT Oncternal Therapeutics, Inc. | FTax withholding Common Stock | -6,266 | $1.02 | $6,391 | 66,726 | Jan 5, 2023 |
Questions about Gunnar F. Kaufmann
Answered from the filings on this page, as of the latest one.
Is Gunnar F. Kaufmann buying or selling?
Not in the last 12 months. Gunnar F. Kaufmann's latest open-market trade on SEC Form 4 was bought $9,824 of ONCT on Jun 12, 2023.
How did Gunnar F. Kaufmann's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gunnar F. Kaufmann has 0.
Where does Gunnar F. Kaufmann file Form 4?
Gunnar F. Kaufmann has filed Form 4 at ONCT (Oncternal Therapeutics, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.